皇隆制药 (834298.OC)

+ 收藏

利润表(皇隆制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 188,147,518.20394,972,711.39201,646,230.22413,008,692.87158,601,250.54
 营业收入(元) 188,147,518.20394,972,711.39201,646,230.22413,008,692.87158,601,250.54
二、营业总成本(元) 179,505,864.60472,253,774.67215,811,706.93433,845,428.23164,307,512.83
 营业成本(元) 86,972,317.92193,279,891.8392,208,728.96178,120,092.6173,809,835.78
 研发费用(元) 21,664,770.8652,420,510.4116,887,548.0244,239,516.3914,845,602.60
 营业税金及附加(元) 2,631,136.274,533,568.652,356,712.715,186,815.121,645,455.46
 销售费用(元) 47,478,792.53175,675,294.7881,968,307.67158,716,815.1850,999,753.68
 管理费用(元) 14,166,085.3832,323,008.7515,214,524.2632,763,402.1515,988,738.62
 财务费用(元) 6,592,761.6414,021,500.257,175,885.3114,818,786.787,018,126.69
  其中:利息费用(元) 6,640,941.2314,006,430.387,129,212.2714,952,093.627,096,186.50
  其中:利息收入(元) 73,953.25153,118.4794,337.29186,849.78105,681.36
三、其他经营收益
 加:投资收益(元) -283,627.94-215,367.03-212,206.82-362,317.73-291,626.56
  其中:对联营企业和合营企业的投资收益(元) -283,627.94-256,311.19-253,150.98-362,370.63-291,627.98
 资产处置收益(元) -16,291.3645,727.75-3,991.92-30,561.33-638,462.77
 资产减值损失(元) 1,003,011.76-2,200,132.15-2,503,864.591,580,012.38855,610.18
 信用减值损失(元) -2,367,137.862,069,867.672,032,471.15-4,035,474.05-378,936.44
 其他收益(元) 2,987,772.2939,741,937.3321,889,536.579,709,739.107,726,701.18
四、营业利润(元) 9,965,380.49-37,839,029.717,036,467.68-13,975,336.991,567,023.30
 加:营业外收入(元) 0.01215,976.650.374.660.71
 减:营业外支出(元) 34,200.00263,029.4740,745.001,245,416.90305,902.87
五、利润总额(元) 9,931,180.50-37,886,082.536,995,723.05-15,220,749.231,261,121.14
 减:所得税费用(元) 957,131.62-1,695,144.64884,356.83740,850.158,357.89
六、净利润(元) 8,974,048.88-36,190,937.896,111,366.22-15,961,599.381,252,763.25
(一)按经营持续性分类
  持续经营净利润(元) 8,974,048.88-36,190,937.896,111,366.22-15,961,599.381,252,763.25
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 9,059,157.29-36,093,052.616,150,063.86-15,774,909.221,834,277.90
  少数股东损益(元) -85,108.41-97,885.28-38,697.64-186,690.16-581,514.65
 扣除非经常性损益后的净利润(元) 6,562,455.40-69,927,751.60-12,458,127.47-22,897,234.23-3,921,249.66
七、每股收益
 一、基本每股收益(元) 0.09-0.370.06-0.160.02
 二、稀释每股收益(元) 0.09-0.370.06-0.160.02
九、综合收益总额(元) 8,974,048.88-36,190,937.896,111,366.22-15,961,599.381,252,763.25
 归属于母公司所有者的综合收益总额(元) 9,059,157.29-36,093,052.616,150,063.86-15,774,909.221,834,277.90
 归属于少数股东的综合收益总额(元) -85,108.41-97,885.28-38,697.64-186,690.16-581,514.65
公告日期 2024-08-282024-04-302023-08-252023-04-282022-08-24
审计意见(境内) 带强调事项段的无保留意见带强调事项段的无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院